Beryl Robinson, in Baton Rouge, LA - Case Manager/Care Coordinator

Beryl Robinson, is a Case Manager/care Coordinator based in Baton Rouge, Louisiana. Beryl Robinson is licensed to practice in * (Not Available) (license number ) and her current practice location is 3888 S Sherwood Forest Blvd Ste F, Baton Rouge, Louisiana. She can be reached at her office (for appointments etc.) via phone at (225) 771-8251.

NPI number for Beryl Robinson is 1013430263 and her current mailing address is 3888 S Sherwood Forest Blvd Ste F, Baton Rouge, Louisiana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1013430263.

Contact Information

	Beryl Robinson,
	3888 S Sherwood Forest Blvd Ste F, Baton Rouge, LA 70816
	(225) 771-8251
	Not Available

Healthcare Provider's Profile

Full Name	Beryl Robinson
Gender	Female
Speciality	Case Manager/care Coordinator
Location	3888 S Sherwood Forest Blvd Ste F, Baton Rouge, Louisiana
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1013430263
Provider Enumeration Date: 07/19/2017
Last Update Date: 07/21/2022

Medical Identifiers

Medical identifiers for Beryl Robinson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013430263	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YM0800X	Counselor - Mental Health	(* (Not Available))	Secondary
171M00000X	Case Manager/care Coordinator	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Beryl Robinson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Beryl Robinson, 3888 S Sherwood Forest Blvd Ste F, Baton Rouge, LA 70816-4400 Ph: (225) 771-8251	Beryl Robinson, 3888 S Sherwood Forest Blvd Ste F, Baton Rouge, LA 70816 Ph: (225) 771-8251

News Archive

Livestock may play important role in epidemiology of leptospirosis in sub-Saharan Africa

Leptospirosis, which affects more than one million people worldwide each year, is known to be transmitted to humans from a wide range of animals. Now, researchers reporting in PLOS Neglected Tropical Diseases have discovered that more than 7 percent of the cattle and 1 percent of sheep and goats in local slaughterhouses in northern Tanzania are infected with Leptospira bacteria.

South Africa to expand rollout of new TB testing machine, but concerns remain about capacity issues

"South Africa will expand its rollout of GeneXpert tuberculosis testing machines, which can diagnose TB and drug-resistant TB within 90 minutes, but concerns remain about the capacity to back up this commitment with supplies and treatment," IRIN reports.

Researchers discover two optimal gene targets for new colorectal cancer test

A study presented today by Mayo Clinic researchers at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago identified two genes that are optimal targets to be analyzed in a new noninvasive test for colorectal cancer developed by Mayo Clinic, in collaboration with Exact Sciences Corporation.

Pulse Therapeutics receives fund to develop novel magnetics technique to destroy blood clots

BioGenerator, a non-profit, seed-stage economic development funding group, today announced that it has led a round of early-stage financing for Pulse Therapeutics, Inc., a St. Louis company headquartered at the Center for Emerging Technologies. Pulse Therapeutics develops innovative magnetism-based technology to safely destroy blood clots related to ischemic stroke and deep vein thrombosis (DVT). Other investors who participated in the round were Missouri Technology Corporation (MTC), Washington University's Olin School of Business Skandalaris Student Venture Fund, and Integrated Magnetics, of Culver City, California. The funds will be used for further pre-clinical development.

Researchers using cognitive therapy to manage female incontinence

After nine years of suffering in silence and living in fear of leaving the house, Anna Raisor, 53, turned to physicians at Loyola University Health System (LUHS) for alternative measures to treat the embarrassing side effects of incontinence.

Beryl Robinson, - Counselor in Baton Rouge, LA